Optimal control model for radiation therapy inverse planning applying the Boltzmann transport equation  by Tervo, J. et al.
Linear Algebra and its Applications 428 (2008) 1230–1249
Available online at www.sciencedirect.com
www.elsevier.com/locate/laa
Optimal control model for radiation therapy inverse
planning applying the Boltzmann transport equation
J. Tervo a,∗, M. Vauhkonen b, E. Boman b
a Department of Mathematics and Statistics, University of Kuopio, P.O. Box 1627, FIN-70211, Kuopio, Finland
b Department of Physics, University of Kuopio, Kuopio, Finland
Received 31 July 2006; accepted 4 March 2007
Available online 24 March 2007
Submitted by Y. Censor
Abstract
We consider an inverse problem related to external radiation therapy treatment planning. The dose
calculation (the forward problem) is based on the Boltzmann Transport Equation (BTE) which models
exactly the transport of charged particles in tissue. The inverse planning (the inverse problem) is formulated
as an optimal boundary control problem. The optimal control variable is the incoming (external) flux and
the output is the dose distribution in patient domain. Both physical and biological cost functions are defined
but here we concentrate on the physically based optimization. The discretization is done by finite element
approximations for which the BTE is expressed in its variational form. In the optimization process of the
discrete model we apply so called parametrization (which may essentially diminish the decision variables in
optimization) of the matrix equations. Parametrization is based on certain linear algebraic decompositions
of matrices. One simulation is presented which show the functionality of the developed methods.
© 2007 Elsevier Inc. All rights reserved.
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1. Introduction
In the field of radiation therapy much research has been done to obtain new innovative
techniques for treating cancer patients with radiation. New equipments and new computational
approaches have been developed but there still is a lack of automatic treatment planning system.
Treatment planning is an inverse problem in nature. In solving the inverse problem one always
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needs a dose calculation model, that is, a physical “dose law” which determines the dose in the
patient based on the knowledge of the radiation flux incident on the surface of the patient domain.
In the mathematical terminology, this means the solution of the forward problem.
For solving the forward problem one has developed and applied various dose calculation
models. Widely used models are variants of so-called pencil beam models which require the
application of a dose deposition kernel. The most accurate, physically rigorous and robust models
are based on the Boltzmann transport equation (BTE) [1,6,8,9,12,15]. Transport equation based
dose calculation models are valid in inhomogeneous material and they also take rigorously into
account the scattering effects. Mainly due to computational problems, BTE based models are not
yet extensively used in solving the forward problem.
In oncological society the solution of the inverse problem, i.e., the concept of “the best plan”
seems not to be absolutely unique. In some cases it may be difficult to measure the optimality
criteria. However, the principles of the optimal plan can be founded either on the physical criteria
or on the biological criteria. Nowadays in practice the criteria are mainly based on physical ones.
In the case of physical criteria one tries to create a prescribed dose distribution in the target
(tumor) such that the dose in the healthy tissue is under certain prescribed value. In addition,
one takes special care of critical organs by demanding that the dose in vulnerable regions is
under certain prescribed level. Some additional constraints (e.g. dose volume constraints) may
be included. Using physical criteria the objective functions are relatively easy to construct and
a lot of various alternatives can be found in literature (e.g. [23,24] and the references therein).
Another possibility in the optimization applying physical criteria is to seek only feasible (nearly
optimal) solutions [5,16]. Recently we have developed optimization algorithms which use directly
the multileaf collimator (MLC) system parameters in optimization [16–19]. The corresponding
delivery quality (objective) functions are usually highly nonlinear and multiextremal. The model
constraints are mainly linear inequalities and so relatively simple.
In the optimization which is based on biological criteria one utilizes statistical data collected
from clinical trials. In the case of biological criteria, two different probabilities, namely the tumor
control probability (TCP) and the normal tissue complication probability (NTCP) are employed in
the treatment planning [3,4,24]. The aim is to provide as high TCP as possible and at the same time
maintain the NTCP at an acceptable level in certain organs of the patient. The biological objective
functions are more difficult to construct and as a rule one can say that the biological objective
functions are mathematically more complex to handle than the physical objective functions.
Recently we have developed an optimal control approach for solving the optimization problem
[20]. In this approach the BTE has been utilized and the optimization problem is solved by the
boundary control optimization theory. In this paper we introduce a radiation treatment planning
approach that is based on the Boltzmann transport equation and optimal control. A novel linear
algebraic parametrization approach is utilized for the discretized model in order to reduce the num-
ber of optimized parameters in the optimization procedure. Solving effectively large dimensional
linear systems and the calculation of the singular value decompositions for them are difficulties
in our approach. The control parameters in this study are the intensities of the applied radiation
fields, though it would be fairly straightforward to formulate the problem also for the case of
MLC. In that case, however, the objective functions become highly nonlinear and the number of
decision parameters increases. Numerical results for two-dimensional patient body are shown in
the paper. In numerical considerations we have concentrated on the use of physical optimization
criteria but the optimization scheme applying the biological optimization criteria is also defined
in the paper. The optimization problems for realistic (3-dimensional patient body) cases are very
large dimensional and they are still computationally too expensive.
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2. Calculation of dose
2.1. Boltzmann transport equation model
Physically the Boltzmann transport equation is based on the particle equilibrium in infinitesimal
small voxels of tissue. The modeling requires the knowledge of the differential and total cross
sections which depend on the nature of interactions of particles. The total dose is obtained as a
superposition of different fields as will be described in detail below (Section 2.3).
We consider only the stationary transport of particles. Assume that ψj = ψj (x,E,), j =
1, 2, 3 are the phase space densities for photons, electrons and positrons, respectively. x =
(x1, x2, x3) is the point in the patient domain V ⊂ R3.  is a point on the unit sphere S of R3.
In the case where elastic collision, inelastic collision and bremsstrahlung are taken into account
the model consists of the following coupled system of partial differential–integral equations
 · ∇ψ1 + K1(ψ1, ψ2, ψ3) = Q1(x, E,),
 · ∇ψ2 + K2(ψ1, ψ2, ψ3) = Q2(x, E,), (2.1)
 · ∇ψ3 + K3(ψ1, ψ2, ψ3) = Q3(x, E,).
The model (2.1) is linear. It neglects some nonlinear interactions which are not essential in dose
calculation. The functionsKj(ψ1, ψ2, ψ3), j = 1, 2, 3 are collision terms resulting from different
kind of interactions (mentioned above). K1,K2,K3 are linear functions of ψ := (ψ1, ψ2, ψ3). The
interactions can be described by the integrals (j = 1, 2, 3)
Kjψ =
3∑
k=1
∫
I
∫
S
σk,j (x, E
′, E,′,)ψk(x,E′,′) d′ dE′ −
3∑
k=1
k,j (x, E)ψk.
Above σk,j (x, E′, E,′,) are differential cross sections andk,j (x, E) are total cross sections.
If the interaction from particle j to particle k is not possible, σk,j = 0. For total cross sections
k,j = 0, j /= k. (2.2)
Finally, Qj(x,E,) are the source terms. These may describe sources in tissue (interior therapy).
The integral
∫
S
f () d denotes the standard surface integral. We denote by I the energy
interval, say [E1, E2]. The solution ψ is defined in the 6-dimensional state space G :=V × I × S.
In the following we denote the system (2.1) more simply by
( · ∇ + K)ψ = Q, (2.3)
where
 · ∇ψ = ( · ∇ψ1, · ∇ψ2, · ∇ψ3)
and Kψ = (K1ψ,K2ψ,K3ψ), Q = (Q1,Q2,Q3). We consider exterior radiation therapy.
Hence we have Q = 0 and the boundary condition is used to model the extrageneous particle
fluxes.
2.2. Photon inflow. The boundary condition
We consider the photon inflow in the stationary case. This corresponds the exterior photon
radiation. Other modalities are similarly considered. We assume that the boundary V is a
Lipschitz-boundary. Then the outward normal ν(x) exists and is it continuous on V in spite
of possibly a set with surface measure zero.
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To take into account the incoming extrageneous flux we must put some (boundary) conditions
for the solution. In the exterior therapy the typical condition for the solution ψ is of the form
ψ2(x, E,) = ψ3(x, E,) = 0 for (x, E,) ∈ V × I × S
such that  · ν(x) < 0,
ψ1(x, E,) = u(x,E,) for (x, E,) ∈ V × I × S
such that  · ν(x) < 0. (2.4)
u is the photon flux density incident on V . We assume that u ∈ L2(V × I × S). The condition
ψ1 = u for  · ν(x) < 0, x ∈ V means that the beam (the flux u) is inwardly on the patch V
and the condition ψj = 0, j = 2, 3 for · ν(x) < 0 means that no other particles generate inward
fluxes.
Remark 1. For the exterior electron radiation the roles of ψ1 and ψ2 are changed in the boundary
condition. Otherwise the boundary condition is same as in (2.4).
2.3. The definition of dose
In practical situations the total dose distribution is computed as follows. Let the incoming
(initial) flux density of the lth field Sl be ul . We assume that ul ∈ L2(l × I × S), where l is
a patch of V through which the radiation is entering into domain V . Let ψl = (ψl1, ψl2, ψl3) be
the flux density corresponding to the field Sl , that is ψl is the solution of the equation
( · ∇ + K)ψl = 0 (2.5)
with the boundary condition
ψl2(x, E,) = ψl3(x, E,) = 0 for (x, E,) ∈ V × I × S
such that  · ν(x) < 0,
ψl1(x, E,) = 0, for (x, E,) ∈ (V \ l ) × I × S
such that  · ν(x) < 0, (2.6)
ψl1(x, E,) = ul(x, E,) for (x, E,) ∈ l × I × S
such that  · ν(x) < 0.
Above
 · ∇ψl := ( · ∇ψl1, · ∇ψl2, · ∇ψl3), Kψl := (K1ψl,K2ψl,K3ψl).
The dose contribution Dl(x) from the field Sl at a point x of the patient domain V is obtained
from the (measurement) integral
Dl(x) =
3∑
j=1
∫
S
∫
I
κj (x, E)ψ
l
j (x, E,) dE d, (2.7)
where κj (x, E) are known (stopping power) factors (κ1(x, E) = 0). The total dose is obtained
from
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D(x) =
L∑
l=1
Dl(x) =
L∑
l=1
3∑
j=1
∫
S
∫
I
κj (x, E)ψ
l
j (x, E,) dE d. (2.8)
The computation of total dose can also be formulated as follows. Define u ∈ L2(V × I × S)
such that
u =
L∑
l=1
ulχl, (2.9)
whereχl : V × I × S → R are the characteristic functions ofl × I × S. Letψ = (ψ1, ψ2, ψ3)
be the solution of the problem
( · ∇ + K)ψ = 0 (2.10)
with the boundary condition
ψ2(x, E,) = ψ3(x, E,) = 0 for (x, E,) ∈ V × I × S
such that  · ν(x) < 0,
ψ1(x, E,) = u, for (x, E,) ∈ V × I × S
such that  · ν(x) < 0, (2.11)
where u is defined by (2.9).
The solution of the problem (2.10)–(2.11) is
ψ =
(
L∑
l=1
ψl1,
L∑
l=1
ψl2,
L∑
l=1
ψl3
)
, (2.12)
where ψl(l = 1, . . . , L) are the solutions of (2.5)–(2.6). The proof follows from the uniqueness
of solutions (2.3)–(2.4) which we will formulate in Section 2.4. Now the total dose is
D(x) =
3∑
j=1
∫
S
∫
I
κj (x, E)ψj (x,E,) dE d, (2.13)
where ψ is the solution of (2.10)–(2.11). We find that (2.10)–(2.11) is exactly the problem (2.3)–
(2.4) with u ∈ L2(V × I × S) given by (2.9).
Remark 2. The energy deposition in a patient is due to the charged particles. Hence in practice
we can assume that κ1(x, E) = 0. More generally the factors κj may depend also on .
2.4. Variational form of equations
Let G be as above and let L2(G) be the Lebesgue space of (real valued) square integrable
functions on G with the usual inner product. Furthermore, let
L2(V × I × S, | · ν| dσ dE d) :=
{
g : V × I × S → R|g is measurable and
∫
S
∫
I
∫
V
| · ν|g2 dσ dE d < ∞
}
,
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where σ is the surface measure on V . Then L2(V × I × S, | · ν| dσ dE d) is a Hilbert space
equipped with the inner product
〈g1, g2〉L2(V×I×S,|·ν| dσ dE d) :=
∫
S
∫
I
∫
V
| · ν|g1g2 dσ dE d.
Denote
D(V × I × S) :={f |V×I×S |f ∈ C∞(R3 × R × S)}.
Let H1 be the completion of D(V × I × S) with respect to the inner product
〈f1, f2〉H1 :=〈f1, f2〉L2(G) + 〈f1, f2〉L2(V×I×S,|·ν| dσ dE d).
Furthermore, let H2 be the completion of D(V × I × S) with respect to the inner product
〈f1, f2〉H2 = 〈f1, f2〉L2(G) + 〈 · ∇f1, · ∇f2〉L2(G).
Finally, let H :=H1 ∩ H2 is equipped with the standard Hilbert space inner product
〈f1, f2〉H = 〈f1, f2〉H1 + 〈f1, f2〉H2 .
For any f ∈ H1 the trace f |V×I×S) is well defined in the sense that there exists a sequence
{fn} ⊂ D(V × I × S) such that
fn → f |V×I×S in L2(V × I × S, | · ν| dσ dE d).
One knows that for each f ∈ H2 the restriction f |V×I×S ∈ L2(K) where K is a compact
subset of
{(x, E,) ∈ V × I × S|| · ν(x)| > 0}
but f |V×I×S is not necessarily in L2(V × I × S, | · ν| dσ dE d) [8, pp. 220–221]. For
ψ, v ∈ H the Green’s formula
〈ψ, · ∇v〉L2(G) + 〈 · ∇ψ, v〉L2(G) =
∫
S
∫
I
∫
V
( · ν)ψv dσ dE d (2.14)
is valid [8, p. 225].
In the product spaces H 3i , i = 1, 2 we use the usual inner products
〈f, h〉H 3i =
3∑
j=1
〈fj , hj 〉Hi
for f = (f1, f2, f3), h = (h1, h2, h3) ∈ H 3i . In the similar way we define the inner product in
H 3.
In the following the subscript “−” refers to the negative part of a function and the subscript “+”
refers to the positive part of a function. The variational formulation of the problem (2.3)–(2.4) is
given by [21].
Theorem 1. Assume that
1. k,j ∈ L∞(V × I ), (2.15)
2. σk,j ∈ C(V × I 2 × S2), (2.16)
3. Qj ∈ L2(G), u ∈ L2(V × I × S). (2.17)
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Then the variational form of the equation (2.10) with the stated boundary condition (2.11) is
given by
B(ψ, v) = F(v), v ∈ H 3, (2.18)
where B(·, ·) : H 3 × H 3 → R is the bilinear form
B(ψ, v) = −〈ψ, · ∇v〉L2(G)3 +
3∑
j=1
∫
S
∫
I
∫
V
( · ν)+ψjvj dσ dE d+ 〈Kψ, v〉L2(G)3
(2.19)
and
F(v) = 〈Q, v〉L2(G)3 +
∫
S
∫
I
∫
V
( · ν)−uv1 dσ dE d. (2.20)
We formulate the following lemma [21]:
Lemma 1. Assume that
1. k,j ∈ L∞(V × I ), (2.21)
2. σk,j ∈ C(V × I 2 × S2). (2.22)
3. There exits κ > 0 such that for ψ ∈ H 3
〈Kψ,ψ〉L2(G)3  κ‖ψ‖2L2(G)3 . (2.23)
Then the bilinear form B(ψ, v) satisfies
B(ψ, v)  C‖ψ‖H 31 ‖v‖H 3 (boundedness) (2.24)
for ψ, v ∈ H 3 and
B(ψ,ψ)  c‖ψ‖2
H 31
(H 31 − coercitivity) (2.25)
for ψ ∈ H 3.
In addition, F ∈ (H 31 )∗ (here the superscript “∗” refers to the adjoint space) and there exists
C > 0 such that
‖ψ‖H 31  C‖F‖, (2.26)
where
‖F‖ :=‖Q‖L2(G)3 +
√∫
S
∫
I
∫
V
|( · ν)−|u2 dσ dE d.
In [2,21] we have proved the following sufficient algebraic criterion for the coercitivity
assumption (2.23)
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Lemma 2. Suppose thatj,j ∈ L∞(V × I ) and σk,j ∈ C(V × I 2 × S2). Furthermore, suppose
that (2.2) is valid and that there exists α > 0 such that almost everywhere (x, E,) ∈ G
j,j (x, E,) −
∫
S
∫
I
3∑
k=1
σk,j (x, E
′, E,′,) dE′ d′  α (2.27)
and
j,j (x, E,) −
∫
S
∫
I
3∑
k=1
σj,k(x, E,E
′,,′) dE′ d′  α (2.28)
for j = 1, 2, 3. Then the assumption
〈Kψ,ψ〉L2(G)3  α‖ψ‖2L2(G)3 (2.29)
is valid.
A physical background can be easily found for the condition (2.27), where the integrations over
energy and angular domains basically describe the total scattering cross sections. The condition
(2.27) states that the sum of these scattering cross sections cannot be larger than the total cross
section itself. This is always true, because the total cross section is the sum of scattering and
absorption cross sections. The physical meaning of the second condition (2.28) is not so clear. It
states that those integrated ‘inverse’ scattering cross sections, which change particles from j to k
cannot be larger than the total cross section of the particle j . However, it seems that this second
condition (2.28) is also physically relevant.
By the boundedness (2.24) the bilinear form B(·, ·) can be extended on H 31 × H 3 (here we
denote the extension again by B(·, ·)). The extension satisfies the estimates
|B(ψ, v)|  C‖ψ‖H 31 ‖v‖H 3 , ψ ∈ H
3
1 , v ∈ H 3 (2.30)
and
B(ψ,ψ)  c‖ψ‖2
H 31
, ψ ∈ H 3. (2.31)
We formulate the following existence result of solutions:
Theorem 2. Suppose that the assumptions of Theorem 1 are valid and that (2.2) and (2.27)–
(2.28) hold. Then the variational equation
B(ψ, v) = F(v), v ∈ H 3 (2.32)
has one and only one solution ψ ∈ H 3.
In addition, F ∈ (H 31 )∗ and
‖ψ‖H 31 
1
c
‖F‖, (2.33)
where
‖F‖  ‖Q‖L2(G)3 +
√∫
S
∫
I
∫
V
|( · ν)−|u2 dσ dE d. (2.34)
Proof. The proof follows from estimates (2.30), (2.31) and the generalized Lax–Milgram
Theorem [22, p. 403]. We omit the details here. 
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Theorem 2 gives the existence of weak solutions for the problem (2.10)–(2.11).
3. Optimal control problem in radiation therapy
3.1. Inverse problem based on physical objectives
The patient domain V ⊂ R3 contains tumor’s (target’s) region T, critical organs’ region C and
normal tissue’s region N and so we have the union V = T ∪ C ∪ N. Let us assume that we have L
fields Sl, l = 1, . . . , L. This means that gantry, couch and collimator angles are determined and
the whole treatment contains L different angle settings.
Above we have found that the dose can be obtained from the functional
D(x) =
3∑
j=1
∫
S
∫
I
κj (x, E)ψj (x,E,) dE d, (3.1)
where ψ is the solution of (2.10)–(2.11). In (3.1) κj (x, E) are known factors (so-called stopping
powers). We assume that κj ∈ L∞(V × I ). Considering the external therapy we have no internal
sources. So Ql = 0 for each field Sl . Applying the above concepts, the inverse radiation treatment
planning problem states:
Suppose that D0 is the prescribed (uniform) dose in tumor T and that DC and DN are the upper
bounds of dose in the critical organ C and in the normal tissue N, respectively. Furthermore,
suppose that the number L and the gantry, couch and collimator angles αl , βl and θl of fields Sl
are given.
Determine the incoming flux u ∈ L2(V × I × S) such that
D(x) = D0, x ∈ T,
D(x)  DC, x ∈ C,
D(x)  DN, x ∈ N. (3.2)
and that
u  0. (3.3)
Tumor, critical organ and normal tissue may be divided into many separate parts and dose
limits may be different in these parts.
Besides the requirements (3.2) one often demands that so called dose volume constraints [3,23]
are fulfilled. Dose volume constraints may be necessary for certain structures, for example for
critical organs. We describe this requirement shortly for critical organ C. Let v(D) be the volume
fraction of C that receives a dose greater than D. We demand that
v(D)  v0 when D  dC, (3.4)
where v0 is a given volume fraction and dC is a given dose. Since the function v = v(D) is a
decreasing function of D the condition (3.4) is equivalent to
v(dC)  v0. (3.5)
The condition (3.5) means that
μ({x ∈ C|D(x)  dC})
μ(C)
 v0, (3.6)
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where μ is the Lebesgue measure. Let H : R → R be the Heaviside function H(x) =
{
1, x  0
0, x < 0 .
Then the dose volume constraint (3.6) can be expressed as
1
μ(C)
∫
C
H(D(x) − dC) dx  v0. (3.7)
In computer programs the Heaviside function H can be accurately replaced by the error func-
tion erf
(x) = 1√π

∫ x
−∞ e
−s2/
2 ds. Furthermore, the requirement (3.6) can be approximated
accurately by the requirement
1
|IC|
∑
p∈IC
erf
(D(xp) − dC)  v0, (3.8)
where IC is a selected finite set of C (for example, the set of nodes in finite element computations).
When the dose volume constraints are taken into account requirements like (3.7) (or 3.8)) are added
to the requirements (3.2).
3.2. Optimal control problem
To clarify the u-dependence of variables we denote ψ = ψ(u), if needed. Let F : L2(V ×
I × S) → (H 3)∗ be the operator defined by
(Fu)(v) =
∫
S
∫
I
∫
V
( · ν)−uv1 dσ dE d.
Note that F(v) = (Fu)(v) (or F = Fu). Using these notations ψ = ψ(u) satisfies the variational
equation
B(ψ(u), v) = (Fu)(v), v ∈ H 3. (3.9)
Let L : L2(G)3 → L2(V ) be the functional
(Lψ)(x) =
3∑
j=1
∫
S
∫
I
κj (x, E)ψj (x,E,) dE d. (3.10)
Then we have for the dose
D = Lψ = Lψ(u). (3.11)
For later needs we notice that the adjoint L∗ : L2(V ) → L2(G)3 of L is given by
L∗v = (κ1v, κ2v, κ3v), v ∈ L2(V ). (3.12)
The dose D(x) must be as near as possible to the described dose D0 in the tumor and the
upperbounds of dose in critical organs and normal tissue may not be violated. Hence we try to
optimize the incoming flux u so that this holds. The concrete implementation of this leads to the
following kind of optimization problems, for example.
Define a cost functional by
J (u) = c1‖D0 − Lψ(u)‖2L2(T)
+ c2‖(DC − Lψ(u))−‖2L2(C) + c3‖(DN − Lψ(u))−‖2L2(N)
+ c4‖(u)−‖2L2(V×I×S) + c5‖u‖2L2(V×I×S), (3.13)
1240 J. Tervo et al. / Linear Algebra and its Applications 428 (2008) 1230–1249
where cj , j = 1, . . . , 5 are positive weights and the subscript “−” refers as above to the negative
part of a function. The first term penalizes the violation of the requirementD0 = D(x), x ∈ T. The
minimization of the second and the third terms tries to maintain the requirements D(x)  DC, x ∈
C and D(x)  DN, x ∈ N. To keep the admissible control set as the whole space L2(V × I × S)
we added a penalty term
c4‖u−‖2L2(V×I×S) (3.14)
which hinders the violation of the constraint u  0. The last (convex) term regularizes the schemes
and helps the optimization process in theory and in numerical considerations. To diminish the
incoming flux u may also have practical importance.
If the dose volume constraint is used, say in critical organ, one adds a penalty term
c6
((
v0 − 1
μ(C)
∫
C
H(Lψ(u) − dC) dx
)
−
)2
,
where the Heaviside function can be replaced by an error function erf
 (as suggested above). The
penalty term for the dose volume constraint can also be replaced by its discrete counterpart
c6
⎛
⎝
⎛
⎝v0 − 1|IC|
∑
p∈IC
erf
((Lψ(u))(xp) − dC)
⎞
⎠
−
⎞
⎠
2
.
Remark 3. To smoothen the dose in the target one may add the term
c7‖∇xLψ(u)‖2L2(T) (3.15)
in the cost function. We leave this consideration here.
As a conclusion we find that the corresponding optimization problem states:
Find the global minimum
min
u∈L2(V×I×S)
J (u) (3.16)
such that
B(ψ(u), v) = (Fu)(v), v ∈ H 3. (3.17)
3.3. Optimization based on biological objectives
In the following we suggest an inverse treatment planning based on the biological response.
Let k denote the probability of the death of a single clonogen at x ∈ T. The probability k depends
on the dose D(x) and so k = k(D(x)). Typically the graph of k is a sigmoidal. The function k
is based on the oncological data and its continuous expression can be obtained using appropriate
basis system and data fitting. Denoting the number density of clonogens by ρ = ρ(x) the tumor
control probability T CP can be expressed as follows [3]:
T CP (D) = e
∫
T ρ(x) ln(k(D(x))) dx. (3.18)
For the normal tissue complication probability NTCP we apply the model based on [11]. For
the organ at risk we get [3]
NTCPC(D) = 1√
2π
∫ (〈D〉Lp−DC,50)/σC
−∞
e−t2/2 dt, (3.19)
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where
〈D〉Lp = 1
μ(C)1/p
‖D‖Lp(C) = 1
μ(C)1/p
(∫
C
|D(x)|p dx
)1/p
.
Here μ(C) is the measure (volume) of C. Parameters DC,50, p and σC are statistical values based
on the oncological data.
Similarly we obtain for the normal tissue
NTCPN(D) = 1√
2π
∫ (〈D〉Lq −DN,50)/σN
−∞
e−t2/2 dt, (3.20)
where
〈D〉Lq = 1
μ(N)1/q
(∫
N
|D(x)|q dx
)1/q
.
Here μ(N) is the measure (volume) of N. Parameters DN,50, q and σN are statistical values based
on the oncological data.
Putting D = Lψ(u) we obtain the probabilities as functions of the incoming flux u
T CP (u) = e
∫
T ρ(x) ln(k((Lψ(u))(x))) dx, (3.21)
NTCPC(u) = 1√
2π
∫ (〈Lψ(u)〉Lp−DC,50)/σC
−∞
e−t2/2 dt,
NT CPN(u) = 1√
2π
∫ (〈Lψ(u)〉Lq −DN,50)/σN
−∞
e−t2/2 dt.
Remark 4. A. For the NTCP there exists also alternative models [3] and these can be similarly
implemented to our algorithms.
B. The organ at risk C can be divided into several disjoint parts C = C1 ∪ · · · ∪ Cn. For
individual Ci the above parameters may be different. For simplicity we assume one organ at risk.
Let pC and pN ∈ [0, 1] be the prescribed probability values (acceptable safes). Using the above
definitions the inverse problem can be stated as follows:
Suppose that pC and pN ∈ [0, 1] are given. Suppose that the number L of fields Sl , gantry,
couch and collimator angles αl , βl , θl of the fields Sl are given.
Determine the incoming flux u ∈ L2(V × I × S) such that T CP (u) is maximal and that
NTCPC(u)  pC, (3.22)
NTCPN(u)  pN (3.23)
and
u  0. (3.24)
We are able to formulate different kinds of optimal and/or feasible problems. We proceed as
follows. Define a cost function
J (u) = c1
(
1
T CP (u) + 1
)
+ c2((pC − NTCPC(u))−)2 + c3((pN − NTCPN(u))−)2
+ c4‖(u)−‖2L2(V×I×S) + c5‖u‖2L2(V×I×S), (3.25)
where cj , j = 1, . . . , 5 are positive weights.
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The corresponding optimization problem states:
Find the global minimum
min
u∈L2(V×I×S)
J (u) (3.26)
such that
B(ψ(u), v) = (Fu)(v), v ∈ H 3. (3.27)
In the following we apply the physical cost function. Optimization results applying biological
objective function will be addressed in future work. The initial solution for the optimization can
be obtained as in the case of physical cost function given below.
4. Discretized model applying FEM
For computer needs we must discretize the above models. We apply here the finite element
method which has some advantages for this problem. For example, the inflow boundary condition
is quite easy to handle (via variational formulations). In addition, the convergence can be proven
(not proven here), if the boundedness and coercitivity estimates given in Section 2 hold.
4.1. Finite element method for the control system
Let Xh be a finite dimensional subspace of H 3 and let Yh be a finite dimensional subspace of
L2(V × I × S). Denote a basis ofXh by {v1, . . . , vN } and denote a basis ofYh by {w1, . . . , wM}.
Let
ψh =
N∑
n=1
αnvn, uh =
M∑
m=1
βmwm. (4.1)
Then the FEM approximation of the variational equation (3.9) is defined as
B(ψh, v) = (Fuh)(v), v ∈ Xh. (4.2)
This requirement leads to the matrix equation
Aα = Bβ, (4.3)
where A ∈ M(N × N), B ∈ M(N × M) such that
A(k, n) = B(vn, vk), B(k,m) = (Fwm)(vk), α =
⎛
⎜⎝
α1
...
αN
⎞
⎟⎠ , β =
⎛
⎜⎝
β1
...
βM
⎞
⎟⎠ . (4.4)
Eq. (4.3) can be put into the form(
A −B) (α
β
)
= 0, (4.5)
which is the control system (3.27) in its discrete form.
4.2. Optimal control system for the discrete model
Denote
D(x) = (Lv1(x) · · · Lvn(x)) .
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Then we find that
(Lψh)(x) = L
(
N∑
n=1
αnvn
)
(x) = D(x)α. (4.6)
To emphasize the dependence of α on β we denote α = α(β). Applying the above approxima-
tions we are able to formulate the optimal control problem as follows. Define a cost functional by
J (β) = c1‖D0 − Dα(β)‖2L2(T)
+ c2‖(DC − Dα(β))−‖2L2(C) + c3‖(DN − Dα(β))−‖2L2(N)
+ c4
∥∥∥∥∥∥
(
M∑
m=1
βmwm
)
−
∥∥∥∥∥∥
2
L2(V×I×S)
+ c5
∥∥∥∥∥
M∑
m=1
βmwm
∥∥∥∥∥
2
L2(V×I×S)
. (4.7)
We can add the penalty term for the dose volume constraint
c6
((
v0 − 1
μ(C)
∫
C
H(Dα(β) − dC) dx
)
−
)2
,
which can be replaced by its discrete counterpart
c6
⎛
⎝
⎛
⎝v0 − 1|IC|
∑
p∈IC
erf
(Dα(β)(xp) − dC)
⎞
⎠
−
⎞
⎠
2
.
One may also add the term to smoothen the dose in the target (when κj and vn are sufficiently
smooth)
c7
∥∥∥∥∥
N∑
n=1
αn∇xLvn
∥∥∥∥∥
2
L2(T)
(4.8)
in the cost function.
As a conclusion we find that the discretized optimal control problem states:
Find the global minimum
min
β∈RM
J (β) (4.9)
such that(
A −B) (α
β
)
= 0. (4.10)
The functionalJ (β) is not generally differentiable. One can however show that the cost function
J : RM → R is locally Lipschitz continuous.
For many commonly used basis {w1, . . . , wM} it is reasonable to assume that the coefficients
βm are bounded
|βm|  C, m = 1, . . . ,M. (4.11)
Hence the global minimum of the above problem exists.
4.3. Parametrization of discrete system
In [20] we gave some simulations using the variational equations for the optimal control
(Section 4.2). Here we concentrate on the numerical results obtained by the parametrization.
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We say that the (control) system (4.10) is parametrized by a matrix S ∈ M(N + M,p) if
(
A −B) (α
β
)
= 0 ⇔
(
α
β
)
= Sγ, ∈ Rp. (4.12)
Let p1, p2 be the canonical projections
p1 : RN+M → RN,
p2 : RN+M → RM.
Denote Sj γ = pj (Sγ ), j = 1, 2. Then α = S1γ, β = S2γ . Hence
ψ ≈ ψh =
N∑
n=1
αnvn =
N∑
n=1
(S1γ )nvn, γ ∈ Rp (4.13)
and
u ≈ uh =
M∑
m=1
βmwm =
M∑
m=1
(S2γ )mwm, γ ∈ Rp. (4.14)
Denote
S1γ =
N∑
n=1
(S1γ )nvn, S2γ =
M∑
m=1
(S2γ )mwm.
We have verified
Theorem 3. The FEM approximation uh,0 for the optimal control u0 of the problem (4.2) is
uh,0 =
M∑
m=1
(S2γ0)mwm, (4.15)
where γ0 ∈ Rp is the global minimum of the unconstrained problem
min
γ∈Rp J (γ ), (4.16)
where
J (γ ) = c1‖D0 − L(S1γ )‖2L2(T)
+ c2‖(DC − L(S1γ ))−‖2L2(C) + c3‖(DN − L(S1γ ))−‖2L2(N)
+ c4‖(S2γ )−‖2L2(V×I×S) + c5‖S2γ ‖2L2(V×I×S). (4.17)
Here the penalty term for the dose volume constraint is
c6
((
v0 − 1
μ(C)
∫
C
H(L(S1γ ) − dC) dx
)
−
)2
.
Note that
L(S1γ ) = DS1γ, L(S2γ ) = D′S2γ,
where D is as above and D′(x) = (w1(x), . . . , wM(x)).
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A good initial point for the optimization is the solution of the quadratic problem
min
γ∈Rp J (γ ), (4.18)
where
J (γ ) = c1‖D0 − L(S1γ )‖2L2(T) + c5‖S2γ ‖2L2(V×I×S). (4.19)
Denote the elements of matrices Sj by S1(n, l) and S2(m, l). We have
Theorem 4. The minimum γ of the problem (4.18) satisfies the linear equations
c1
N∑
n=1
S1(n, l)〈L∗(eT(LS1γ )), vn〉L2(G)3 − c5
M∑
m=1
S2(m, l)〈S2γ,wm〉L2(V×I×S)
= c1
N∑
n=1
S1(n, l)〈L∗(eTD0), vn〉L2(G)3 , l = 1, . . . , p, (4.20)
where eT is the “extension by zero operator” from the set T on V.
Proof. The minimum point satisfies J ′(γ ) = 0. We find that
J ′(γ )y = 2c1〈D0 − LS1γ, LS1y〉L2(T) + 2c5〈S2γ, S2y〉L2(V×I×S)
= 2c1〈L∗(eT(D0 − LS1γ ), S1y〉L2(G)3 + 2c5〈S2γ, S2y〉L2(V×I×S). (4.21)
For any v ∈ L2(G)3 we have
〈v, S1y〉L2(G)3 =
〈
v,
N∑
n=1
(S1y)nvn
〉
L2(G)3
=
〈
v,
N∑
n=1
p∑
l=1
S1(n, l)ylvn
〉
L2(G)3
=
p∑
l=1
M∑
n=1
S1(n, l)〈v, vn〉L2(G)3yl
and similarly for any w ∈ L2(V × I × S)
〈w, S2y〉L2(V×I×S) =
p∑
l=1
M∑
m=1
S2(m, l)〈w,wm〉L2(V×I×S)yl.
Hence the assertion follows from (4.21). 
Since
L∗(eT(LS1γ )) =
N∑
q=1
(S1γ )qL∗(eT(Lvq)) =
p∑
j=1
N∑
q=1
S1(q, j)L∗(eT(Lvq))γj (4.22)
and
S2γ =
p∑
j=1
M∑
r=1
S2(r, j)wrγj , (4.23)
γ can be immediately solved from (4.20).
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4.4. Compatibility operator for the discrete system
Let F ∈ M(m, n) be a matrix. We consider the parametrization of the equation FX = 0 that
is, we consider the existence of a matrix S ∈ M(n, p) such that
FX = 0 ⇔ X = SY. (4.24)
We recall the following well-known theorem (Singular Value Decomposition).
Theorem 5. Suppose that the matrix F ∈ M(m, n) has rank r. Then there exist orthogonal
matrices U ∈ M(m,m) and V ∈ M(n, n) such that
U∗FV =
(
Dr 0
0 0
)
=: D ∈ M(m, n), (4.25)
where Dr ∈ M(r, r) is a nonsingular diagonal matrix.
Proof. See e.g. [10]. 
In (4.25) the diagonal elements of Dr are √μj , j = 1, . . . , r where μj are the nonzero eigen-
values of the positive semidefinite symmetric matrix F∗F ∈ M(n, n) (in decreasing order). From
Theorem 5 it follows:
Corollary 1. For any matrix F ∈ M(m, n) the parametrization can be given by S = VP ∈
M(m, n − r), where P =
(
0
In−r
)
.
From Corollary 1 we find that the system (A −B)
(
α
β
)
has a parametrization. This parametriza-
tion is useful for us since applying it the optimization contains only n − rank(A −B) free
parameters.
5. Numerical results and discussion
To simulate the use of parametrization in the optimal control, the FEM is used for one scalar (non
coupled) BTE in 2D spatial domain. Then the angular domain is flattened to be θ ∈ [0, 2π ],  =
(sin θ, cos θ). This neglects the scattering out of the 2D plane. As mentioned in the introduction
real spatially 3D simulations are still computationally too expensive. Our aim here is that the
optimal control model works in general. The phantom and incoming particles are artificial. All
the computations are made using MATLAB in a normal PC (2 GHz Pentium IV with 2 GB of
total memory).
The spatial domain [0, 20] × [−10, 10] cm2 is divided into 100 rectangular elements having
121 node points. The angular domain [0, 2π ] is divided into 8 evenly distributed intervals with
8 node points and energy interval [0.1, 1] MeV consisted of 3 evenly distributed intervals with 4
node points. Thirty-six spatial boundary nodes are used as source nodes. The source nodes and
spatial geometry is shown in Fig. 1.
The energy of the incoming radiation is restricted such that only maximum energy is allowed
and the intensities of the directions of the source nodes are optimized. Thus, N = 121 · 8 · 4 =
3872 and M = 36 · 3 = 108, in which only those three inward angular node points for which
 · ν < 0 are included at each spatial node. For the finite element discretization we refer to [2],
in which we have solved the BTE forward problem. The matrix S is computed using SVD, which
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Fig. 1. On the left are the optimized directions of boundary flux intensities. On the right is the optimized dose distribution
with isodose curves, in which 100% corresponds 10 Gy. Also the spatial grid and source nodes are shown. The dark gray
area defines the tumor and the light gray area defines the critical organ.
took approximately three hours. The initial point is achieved from the solution of the quadratic
problem (4.18), in which c1 = 1, c5 = 10−6 and D0 = 10 Gy. Simulated annealing [7] is used in
the global optimization of the unconstrained problem (4.16), in which c1 = 1, c2 = 1.5, c3 = 0.5,
c4 = 1, c5 = 0, D0 = 10 Gy, DN = 5 Gy and DC = 2 Gy. The computation of the initial point
took a few seconds and the global optimization took approximately one hour. The optimized
intensities of different directions and the dose distribution with isodose curves are shown in
Fig. 1.
It can be seen from Fig. 1 that the optimization works in general. 90% isodose curve conforms
quite well to the tumor area while the critical organ receives relatively low dose, i.e., less than
40% of the prescribed dose for the tumor. Small areas of high dose are present at the normal
tissue, which might be removed by adding more weight to the normal tissue criterion. However,
this may pose violation in other dose requirements. With parametrization the number of unknown
variables is decreased from N + M = 3980 to M = 108 and the global optimization is much
easier to accomplish. Here the idea was to demonstrate the use of some kind of tomotherapy
approach, in which the directions of the small fields with preset energies are optimized. In the
case where we apply conventional treatment planning we must choose the admissible space of
control variables as described below in Conclusions. We shall not give any simulation for that
case here. These will be issued in subsequent works. In Fig. 1 it can be seen that some of the
optimized directions are zero or they are very small. These could be neglected and the ‘treatment’
could be done using only those meaningful directions. Near the corners there are intensities at
directions which are wrong. These errors occur because the FEM causes some instability to the
solution of the forward problem at the corner nodes.
6. Conclusion
Optimal dosing of radiation on tumors while avoiding the healthy parts of the body within the
tolerance is a necessity in successful radiation therapy treatment planning. Here the planning is
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based on the Boltzmann Transport Equation and optimal boundary control model. Our approach
contains various subfields such as
1. The solution of the forward problem. We have applied here the BTE which is most relevant
from a physical point of view. This modeling needs correct cross sections and their study is
one part of the research.
2. Discretization for computer needs. We used FEM approach which seems to be well-suited for
this problem. Our selection of element basis system may not be optimal. E.g. the adaptivity
of the grid and wavelet based basis system certainly improves the computations. Also the
so called multi group methods (for energy variable) have benefits and we are aiming to study
them in near future. Other potential possibility for the discretization is to apply (wavelet based)
collocation method. In any case the BTE in its discrete form is large dimensional linear system
of equations.
3. The optimal solution of the inverse problem. This needs the selection of the cost function. We
used physically based criteria for the cost but we also formulated how the optimization can
be founded on biological cost functions. In both cases the cost functions are multiextremal
and global optimizations or good initializations are needed. To diminish the complexity of
the optimization we applied novel approach, so called parametrization, to handle the large
dimensional linear system mentioned in item 2.
Multileaf collimator (MLC), have provided new facilities in dose delivery for a patient [23,24].
The MLC provides use of intensity modulated treatment techniques allowing construction of three-
dimensional and conformal dose distributions with sharp dose gradients. The determination of
MLC parameters, that is, locations and time lengths of subfields (in the multiple static delivery
technique) or velocities of leaf trajectories (in the dynamical delivery technique) such that the
incoming intensity distribution, produces the desired dose distribution is the practical aim in
modern inverse radiotherapy treatment planning. Nowadays, in practice one first optimizes the
incoming flux (such as in this contribution) and afterward uses some optimization algorithm (“leaf
sequencer”) to set the MLC parameters optimally. In our approach it is also possible to use MLC
parameters as optimal control variable. We omit these formulations here. The key idea is that we
are able to express the incoming flux u as a function of MLC trajectories (see [14,17,19]). The
“direct MLC optimization” has obvious benefits. One of its shortcomings is that it leads to more
severe nonlinearities and so the present global optimization algorithms and computer researches
are still not sufficient to solve these problems in reasonable time.
Monodirectionality (for each field) is nowadays in general a practical requirement but in future
it is possible to use multidirectional incoming fluxes applying, e.g. robotics. In the monodirectional
case or more generally cases where the direction or energy of the incoming flux is constraint, we
simply choose
L2(1 × Iad,1 × Sad,1) × · · ·L2(L × Iad,L × Sad,L)
for the control space where Iad,l and Sad,l are the admissible energies and directions for the
incoming flux, respectively. In strictly monodirectional and monoenergetic case we choose
(Fu)(v) =
L∑
l=1
∫
l
(0,l · ν)−ul(x)v1(x, E0,l ,0,l) dσ, (6.1)
where ul = ul(x).
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We conclude that the parametrization can be used in solving the BTE based control problem
in radiotherapy purposes. Further studies needs to be done in making the parametrization easier
to compute. We applied SVD in parametrization, but more sophisticated linear algebraic methods
certainly exist. Also the possibility to use approximations for the parametrization has to be studied
as well. Furthermore, with better global optimizers (see e.g. [14]) the global optimization would
be more powerful. These issues will be considered in future work.
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